Most Popular Choices
Share on Facebook 8 Printer Friendly Page More Sharing
Life Arts   

MHRA and Fake Drugs

By       (Page 1 of 1 pages)   No comments
Message ROBERT FIDDAMAN
So there has been a lot of press lately regarding the MHRA busting online pharmacies selling fake obesity drugs - I'd give them a round of applause for their achievements but really think they should be busting large Pharmaceutical Companies for mass producing fake anti-depressants... after all, they don't all do what they say on the packet do they? In fact, the most important information is left off the packet or patient information leaflet.

Isn't it about time the MHRA got their priorities in order?

Wait! How could they possibly bust the very same companies that fund them?

Easy to bust an online pharmacy though as these are, in the main, some collective group of individuals who spotted a lucrative gap in the market, same goes for Viagra and anti-baldness pills.

Who are losing out to these online pharmacies? The MHRA? Nah

The Pharmaceutical Companies Ladies and Gents. The MHRA will bend over backwards to help the hand that feeds them. Get the fake drugs off the shelves because our funders are losing money. Wouldn't surprise me if the MHRA had been given directives to make this a priority.

Meantime, we have the tired, dragged out MHRA investigation into GlaxoSmithKline. Four years and nothing!

So, MHRA - I lay down the gauntlet

SSRi's continue to be prescribed in this country (UK). Your promise to safeguard human health is wearing thin. You are safeguarding pharma profit and that is utterly shameful.

Don't get me wrong - you SHOULD bust these online pharmacies selling fake drugs but you should also get your finger outta and bust GlaxoSmithKline et al for selling fake anti-depressants to the very same people you promised to protect!

Prof. Kent Woods at the helm of the MHRA is incompetent - though no doubt he believes he is the bees knees with the 'major' busts recently of small online pharmacies.

Go for the big guns Kent... or would that leave a vast hole in the MHRA's budget?

We can at least all sleep soundly at night safe in the knowledge that a few wannabe entrepreneurs have been captured by Woods and his crack team of investigators. Well those of us who haven't been left with irregular sleep patterns by Seroxat can!

One can only imagine the pats on the back the MHRA are getting from pharma huh... more like wads in the back pocket I suspect.

The MHRA - Safeguarding Human Health - Yeh right!
Rate It | View Ratings

ROBERT FIDDAMAN Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Robert Fiddaman is the author of the book, 'The evidence, however, is clear...the Seroxat scandal'. He has been writing about the pharmaceutical industry and medicine regulators for 7 years. His blog, Seroxat Sufferers, has become popular amongst (more...)
 
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

A Chemical Imbalance - The Serotonin Myth

Billion Dollar Drug Company Law Firm Restructures Connecticut Welfare System

Psychiatric Medication or Play Therapy?

Who Killed Japanese Culture?

Glaxo, Myodil and The UK Regulator

Paxil Study 329 All Over Again?

To View Comments or Join the Conversation:

Tell A Friend